Susquehanna International Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $604M | Sell |
2,775,900
-878,500
| -24% | -$195M | 0.07% | 228 |
|
|
2025
Q4 | $835M | Sell |
3,654,400
-1,306,200
| -26% | -$298M | 0.1% | 159 |
|
|
2025
Q3 | $1.15B | Sell |
4,960,600
-334,100
| -6% | -$68M | 0.13% | 120 |
|
|
2025
Q2 | $983M | Buy |
5,294,700
+440,800
| +9% | +$81.9M | 0.14% | 111 |
|
|
2025
Q1 | $1.02B | Sell |
4,853,900
-180,500
| -4% | -$35.1M | 0.17% | 88 |
|
|
2024
Q4 | $895M | Buy |
5,034,400
+1,040,400
| +26% | +$191M | 0.14% | 107 |
|
|
2024
Q3 | $789M | Buy |
3,994,000
+850,600
| +27% | +$159M | 0.14% | 121 |
|
|
2024
Q2 | $539M | Buy |
3,143,400
+166,900
| +6% | +$27.6M | 0.1% | 153 |
|
|
2024
Q1 | $542M | Sell |
2,976,500
-1,131,600
| -28% | -$195M | 0.09% | 161 |
|
|
2023
Q4 | $637M | Sell |
4,108,100
-261,800
| -6% | -$38.2M | 0.12% | 128 |
|
|
2023
Q3 | $651M | Buy |
4,369,900
+654,800
| +18% | +$96.1M | 0.14% | 95 |
|
|
2023
Q2 | $501M | Sell |
3,715,100
-194,100
| -5% | -$28.5M | 0.1% | 132 |
|
|
2023
Q1 | $623M | Sell |
3,909,200
-237,500
| -6% | -$36.3M | 0.13% | 102 |
|
|
2022
Q4 | $670M | Buy |
4,146,700
+852,100
| +26% | +$131M | 0.17% | 85 |
|
|
2022
Q3 | $442M | Sell |
3,294,600
-1,483,700
| -31% | -$213M | 0.11% | 136 |
|
|
2022
Q2 | $732M | Buy |
4,778,300
+151,500
| +3% | +$23.1M | 0.18% | 66 |
|
|
2022
Q1 | $750M | Sell |
4,626,800
-117,500
| -2% | -$17.1M | 0.13% | 103 |
|
|
2021
Q4 | $642M | Sell |
4,744,300
-22,400
| -0.5% | -$2.65M | 0.1% | 155 |
|
|
2021
Q3 | $514M | Sell |
4,766,700
-1,337,900
| -22% | -$153M | 0.07% | 233 |
|
|
2021
Q2 | $688M | Buy |
6,104,600
+2,203,700
| +56% | +$248M | 0.1% | 160 |
|
|
2021
Q1 | $422M | Buy |
3,900,900
+541,500
| +16% | +$57.9M | 0.07% | 248 |
|
|
2020
Q4 | $360M | Buy |
3,359,400
+482,500
| +17% | +$46.4M | 0.06% | 245 |
|
|
2020
Q3 | $252M | Sell |
2,876,900
-1,775,400
| -38% | -$167M | 0.05% | 285 |
|
|
2020
Q2 | $457M | Buy |
4,652,300
+264,400
| +6% | +$23.3M | 0.11% | 146 |
|
|
2020
Q1 | $334M | Buy |
4,387,900
+501,000
| +13% | +$42.7M | 0.11% | 152 |
|
|
2019
Q4 | $344M | Sell |
3,886,900
-790,700
| -17% | -$65.6M | 0.1% | 158 |
|
|
2019
Q3 | $354M | Buy |
4,677,600
+1,126,000
| +32% | +$77.2M | 0.12% | 137 |
|
|
2019
Q2 | $258M | Buy |
3,551,600
+1,685,600
| +90% | +$132M | 0.09% | 175 |
|
|
2019
Q1 | $150M | Sell |
1,866,000
-2,414,700
| -56% | -$198M | 0.06% | 266 |
|
|
2018
Q4 | $395M | Buy |
4,280,700
+1,397,700
| +48% | +$123M | 0.16% | 100 |
|
|
2018
Q3 | $273M | Buy |
2,883,000
+32,600
| +1% | +$3.09M | 0.09% | 184 |
|
|
2018
Q2 | $264M | Buy |
2,850,400
+185,600
| +7% | +$18.1M | 0.09% | 184 |
|
|
2018
Q1 | $252M | Sell |
2,664,800
-373,600
| -12% | -$41M | 0.09% | 179 |
|
|
2017
Q4 | $294M | Sell |
3,038,400
-236,700
| -7% | -$22.3M | 0.1% | 159 |
|
|
2017
Q3 | $291M | Sell |
3,275,100
-1,482,200
| -31% | -$113M | 0.11% | 148 |
|
|
2017
Q2 | $345M | Sell |
4,757,300
-1,060,800
| -18% | -$71.3M | 0.15% | 106 |
|
|
2017
Q1 | $379M | Buy |
5,818,100
+1,778,000
| +44% | +$112M | 0.19% | 83 |
|
|
2016
Q4 | $253M | Buy |
4,040,100
+872,900
| +28% | +$53.3M | 0.13% | 127 |
|
|
2016
Q3 | $200M | Sell |
3,167,200
-320,100
| -9% | -$20.7M | 0.1% | 161 |
|
|
2016
Q2 | $216M | Buy |
3,487,300
+1,050,100
| +43% | +$64M | 0.12% | 140 |
|
|
2016
Q1 | $139M | Sell |
2,437,200
-165,000
| -6% | -$9.2M | 0.07% | 219 |
|
|
2015
Q4 | $154M | Sell |
2,602,200
-1,022,900
| -28% | -$58.9M | 0.07% | 240 |
|
|
2015
Q3 | $197M | Sell |
3,625,100
-238,500
| -6% | -$15.5M | 0.09% | 202 |
|
|
2015
Q2 | $260M | Buy |
3,863,600
+793,600
| +26% | +$51.8M | 0.11% | 146 |
|
|
2015
Q1 | $180M | Sell |
3,070,000
-698,300
| -19% | -$42.2M | 0.08% | 221 |
|
|
2014
Q4 | $247M | Buy |
3,768,300
+807,600
| +27% | +$50.9M | 0.1% | 193 |
|
|
2014
Q3 | $171M | Buy |
2,960,700
+1,013,500
| +52% | +$56.3M | 0.07% | 250 |
|
|
2014
Q2 | $110M | Sell |
1,947,200
-263,300
| -12% | -$13.8M | 0.05% | 343 |
|
|
2014
Q1 | $114M | Buy |
2,210,500
+298,200
| +16% | +$15.1M | 0.05% | 309 |
|
|
2013
Q4 | $101M | Sell |
1,912,300
-274,500
| -13% | -$13.5M | 0.05% | 350 |
|
|
2013
Q3 | $97.8M | Buy |
2,186,800
+740,400
| +51% | +$32.8M | 0.05% | 321 |
|
|
2013
Q2 | $59.8M | Buy |
+1,446,400
| New | +$63.3M | 0.03% | 479 |
|
Other funds holding ABBV
VCM
VPM
Susquehanna International Group's ABBV Position: Q1 2026 in Review
Susquehanna International Group increased its AbbVie (ABBV) stake by 51% in Q1 2026, buying an estimated $32.2M and bringing the position to 431,015 shares worth $93.7M. The position accounts for 0.01% of the portfolio, ranked #873.
Susquehanna International Group first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $349M in Q4 2021. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Susquehanna International Group held 431,015 shares of AbbVie worth $93.7M as of Q1 2026.
- Susquehanna International Group bought 145,084 AbbVie shares in Q1 2026, an estimated $32.2M.
- AbbVie made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #873 holding.
- Susquehanna International Group first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's AbbVie position peaked at $349M in Q4 2021.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.